I 
Page 4 of 6 
UNDERSTANDING OF PARTICIPANTS 
7. I have been given an opportunity to ask any questions concerning the investigational 
cancer treatment regimen involved and the investigator has been willing to reply to my 
inquiries. This investigational drug regimen will be administered under the above 
numbers, titled and described clinical research protocol at this institution. I hereby 
authorize Dr. the attending physician/investigator and designated 
associates to administer the investigational cancer treatment. 
8. I have been told and understand that my particicpation in this clinical research study is 
voluntary. I may decide not to participate, or withdraw my consent and discontinue my 
participation at any time. Such action will be without prejudice and there shall be no 
penalty or loss of benefits to which I may otherwise be entitled, and I will continue to 
received treatment by my physician at this institution. 
Should I decide not to participate or withdraw my consent from participation in this 
clinical research, I have been advised that I should discuss the consequences or effects 
of my decision with my physician. 
In addition, I understand that the investigator may discontinue the clinical research study 
if, in the sole opinion and discretion of the investigator, the study or treatment offers me 
little or no future benefit, or the supply of medication ceases to be available or other 
causes prevent continuation of the clinical research study. The investigator will notify 
me should such circumstances arise and my physician will advise me about available 
2 treatments which may be of benefit at that time. 
I will be informed of any new findings developed dining the course of this clinical 
research study which may relate to my willingness to continue participation in the study. 
9. I have been assured that confidentiality will be preserved except that qualified monitors 
from the Food and Drug Administration may review my records where appropriate and 
necessary. My name will not be revealed in any reports or publications resulting from 
this study, without my expressed consent. 
10. I have been informed that should I suffer any injury as a result of participation in this 
research activity, reasonable medical facilities are available for treatment at this 
institution. I understand, however, that I cannot expect to receive any financial 
compensation from this institution for such injury. 
HSPC #91-10-442 
Date of expiration 
Recombinant DNA Research, Volume 15 
[557] 
